glp-1 news october 16 2025 Monster of 2025: Ads – Mother Jones As GLP-1 Drugs Go Mainstream,

Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice

These benefits appeared to stem from the modulation of enteric neuronal function and tight junction expression

Symptoms of indigestion usually appear in the early stages of medication, and with the prolongation of medication time, most patients' symptoms will gradually improve

Diabetes Care 39 Suppl 1, S4-5, (2016)

doi: 10.1016/j.molmet.2019.09.010 42 AndrikouETsioufisCAndrikouILeontsinisITousoulisDPapanasN

29 This is not surprising, since the previous result was obtained on a fraction of the present dataset